Can consumers file complaints for misleading online pharmaceutical ads?

Misleading advertisements for pharmaceutical products can be dangerous, especially when they promise unrealistic health benefits, claim cures for diseases, or promote unsafe medications. Such deceptive advertising not only undermines consumer trust but also poses serious health risks. Fortunately, consumers are protected by consumer protection laws, and there are several channels to report and resolve complaints against misleading pharmaceutical ads. Whether through e-commerce platforms, advertising authorities, or consumer forums, consumers have the right to take action against deceptive advertising.

Steps to File Complaints for Misleading Online Pharmaceutical Ads

Step 1: Collect Evidence

• Take Screenshots or Record Ads: Capture clear images or videos of the misleading advertisement. This may include the advertisement text, product images, website URLs, and any claims made about the product’s effectiveness or safety.
• Document Claims: Make a note of specific claims made in the ad, such as curing diseases, healing medical conditions, or providing unrealistic health benefits.

Step 2: Contact the Advertiser or Seller

• Reach out to the seller or advertiser directly if possible. Inform them about the misleading nature of their advertisement and request a correction or removal of the false claims. Often, sellers may take down the ad voluntarily if they are informed about violations.

Step 3: Report the Ad to Regulatory Authorities

• Advertising Standards Council of India (ASCI): In India, the ASCI regulates misleading advertisements and has specific guidelines for pharmaceutical advertising. You can file a complaint with ASCI for misleading or false claims made by online pharmaceutical ads.
• Food and Drug Administration (FDA): In the United States, you can report misleading pharmaceutical ads to the FDA, which oversees the safety and advertising of drugs. In India, the Central Drugs Standard Control Organization (CDSCO) is the regulatory authority responsible for ensuring compliance with pharmaceutical product advertising standards.
• National Advertising Division (NAD): In the United States, NAD resolves complaints related to deceptive advertising practices.
• Consumer Protection Act, 2019: Consumers can file complaints under this Act if they feel deceived by false or misleading advertisements for pharmaceutical products.

Step 4: File a Complaint with Consumer Forums

• If the issue persists, you can file a complaint with consumer forums such as:
  • District Consumer Forums or National Consumer Disputes Redressal Commission (NCDRC) in India.
  • Federal Trade Commission (FTC) in the United States.
• Provide evidence of the misleading advertisement, any harm caused (such as health risks or financial loss), and your attempts to resolve the issue with the advertiser or seller.

Step 5: Report the Ad on E-Commerce Platforms

• If the advertisement is posted on an e-commerce platform like Amazon, Flipkart, or eBay, you can report the misleading product listing directly to the platform. E-commerce platforms often have mechanisms to address false advertising.
• Ensure that you provide detailed evidence, including product descriptions, claims made in the ad, and the harm caused by the misleading claims.

Step 6: Seek Legal Action (If Necessary)

• If the misleading advertisement has caused financial harm or health risks, you can seek legal remedies:
  • File a civil suit against the advertiser or seller for fraudulent advertising under consumer protection laws.
  • If there is an element of health harm, you can also pursue a criminal case for endangering public health.

Legal Protections and Consumer Rights Regarding Misleading Pharmaceutical Ads

Consumer Protection Act, 2019 (India)

• This law empowers consumers to file complaints against misleading advertisements and seek compensation for any loss incurred due to deceptive marketing. False claims in pharmaceutical ads can lead to both civil liability and criminal charges under this Act.
• Section 2(1)(r) of the Consumer Protection Act, 2019 defines misleading advertising as any advertisement that misrepresents facts, deceptively promotes a product, or fails to disclose harmful effects.

Food and Drug Administration (FDA) (USA)

• The FDA monitors the advertising of pharmaceutical products and ensures that all claims about the safety, efficacy, and benefits of drugs are truthful and substantiated. If an advertisement is misleading, the FDA can issue warnings or take enforcement actions.
• Misleading advertisements may also violate the Federal Food, Drug, and Cosmetic Act, leading to fines or other legal actions against the advertiser.

ASCI Guidelines (India)

• The Advertising Standards Council of India (ASCI) ensures that all advertisements comply with established standards of truthfulness. Pharmaceutical ads in India must not make unsubstantiated claims, especially regarding health benefits, cures, or safety.
• ASCI has a dedicated healthcare advertising code that prohibits misleading claims about medications, treatments, and wellness products.

Central Drugs Standard Control Organization (CDSCO) (India)

• The CDSCO regulates the advertising of pharmaceutical products in India. Any ad that misleads consumers about the efficacy or safety of a drug or product violates Indian drug laws.

Example of Filing a Complaint for Misleading Online Pharmaceutical Ads

Scenario:

A consumer comes across an online advertisement for a herbal medicine claiming to cure diabetes within a week. The ad promises that the product is FDA-approved and has no side effects, but the consumer suspects that the claims are false and that the product is not FDA-approved.

Steps the Consumer Should Take:

• Step 1: Capture the screenshot of the ad, highlighting the misleading claims (e.g., curing diabetes, no side effects).
• Step 2: Contact the advertiser or e-commerce platform to report the misleading ad and request removal.
• Step 3: File a complaint with the Advertising Standards Council of India (ASCI) or the Central Drugs Standard Control Organization (CDSCO).
• Step 4: If the ad remains active and the issue is not resolved, escalate the matter to a consumer forum or seek legal action for fraudulent advertising.

Outcome:

The advertiser is fined, the misleading ad is removed, and the consumer may be entitled to compensation for any financial loss or health risk caused by the misleading claims.

Conclusion

Consumers have the right to file complaints against misleading pharmaceutical advertisements, which can lead to potential health risks and financial losses. By utilizing regulatory bodies, consumer forums, and legal channels, consumers can address deceptive practices in the pharmaceutical industry and seek compensation or corrective actions for misleading ads.